Milestone Pharmaceuticals (NASDAQ:MIST) has launched a public offering to raise capital, that includes common shares, alongside both Series A and Series B warrants. For certain, investors will have the option…
Tag:
Pharmaceuticals
-
-
Stocks
Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.
-
NRx Pharmaceuticals advances relationship with Anson funds with $8.9M financing